We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

193 hedge funds and large institutions have $391M invested in ImmunityBio in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 63 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 21

37% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 46

17% more funds holding

Funds holding: 165 → 193 (+28)

10% more capital invested

Capital invested by funds: $357M → $391M (+$34.1M)

0.91% less ownership

Funds ownership: 9.85% → 8.95% (-0.91%)

31% less call options, than puts

Call options by funds: $24.8M | Put options by funds: $35.9M

Holders
193
Holders Change
+28
Holders Change %
+16.97%
% of All Funds
2.79%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
51
Increased
63
Reduced
46
Closed
21
Calls
$24.8M
Puts
$35.9M
Net Calls
-$11.1M
Net Calls Change
-$13.2M

Top Buyers

1
Jane Street
Jane Street
New York
+$9.28M
2
UBS AM
UBS AM
Illinois
+$9.2M
3
BlackRock
BlackRock
New York
+$6.91M
4
First Trust Advisors
First Trust Advisors
Illinois
+$5.85M
5
AWM
Accurate Wealth Management
Florida
+$3.69M

Top Sellers

1
State Street
State Street
Massachusetts
-$41.7M
2
Invesco
Invesco
Georgia
-$7.95M
3
Citigroup
Citigroup
New York
-$6.72M
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$5.77M
5
PA
Perceptive Advisors
New York
-$5.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Skandinaviska Enskilda Banken (SEB)
26
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.71M – – –
Swiss National Bank
27
Swiss National Bank
Switzerland
$1.66M – – –
National Bank of Canada
28
National Bank of Canada
Quebec, Canada
$1.65M +$1.37M +207,989 +376%
Corient Private Wealth
29
Corient Private Wealth
Florida
$1.4M +$3.63K +550 +0.2%
MG
30
Marex Group
$1.38M +$1.19M +181,100 +479%
Citadel Advisors
31
Citadel Advisors
Florida
$1.37M +$1.43M +216,930 +451,938%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$1.34M +$164K +24,802 +13%
Balyasny Asset Management
33
Balyasny Asset Management
Illinois
$1.31M +$1.37M +207,196 New
William Blair & Company
34
William Blair & Company
Illinois
$1.31M -$704K -106,742 -34%
AllianceBernstein
35
AllianceBernstein
Tennessee
$1.3M +$175K +26,600 +15%
CAC
36
Cowen and Company
New York
$1.26M +$1.32M +200,000 New
Franklin Resources
37
Franklin Resources
California
$1.26M -$1.27M -192,571 -49%
DekaBank Deutsche Girozentrale
38
DekaBank Deutsche Girozentrale
Germany
$1.23M -$58.6K -8,892 -4%
CA
39
Clearstead Advisors
Ohio
$1.19M +$1.24M +188,500 New
VOYA Investment Management
40
VOYA Investment Management
Georgia
$1.14M +$901K +136,656 +312%
Deutsche Bank
41
Deutsche Bank
Germany
$1.13M +$783K +118,833 +197%
Barclays
42
Barclays
United Kingdom
$1M -$1.5M -226,881 -59%
EAM
43
Erste Asset Management
Austria
$1M – – –
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$836K -$7.66K -1,161 -0.9%
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$828K +$45.4K +6,882 +6%
Legal & General Group
46
Legal & General Group
United Kingdom
$827K +$104K +15,754 +14%
RAM
47
Readystate Asset Management
Illinois
$789K +$823K +124,885 New
SC
48
Sculptor Capital
New York
$774K -$947K -143,700 -54%
LPL Financial
49
LPL Financial
California
$761K +$394K +59,727 +98%
MASUI
50
MIRAE ASSET SECURITIES (USA) INC.
New York
$726K +$758K +114,939 New
1
2
3 4 5

IBRX Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2024, worth a combined $391M — up 9.6% from $357M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new IBRX positions and 21 closed out — a net gain of 30 holders — while 63 added to existing stakes and 46 trimmed.

The largest buyer was Jane Street, adding an estimated $9.28M. The largest seller was State Street, cutting an estimated $41.7M.

  • 193 institutional investors held ImmunityBio (IBRX) as of Q2 2024, up from 165 in Q1 2024.
  • Funds reported $391M of ImmunityBio stock for Q2 2024, up 9.6% quarter-over-quarter.
  • 51 funds opened new ImmunityBio positions in Q2 2024 and 21 closed out, a net change of +30 holders.
  • The largest ImmunityBio buyer in Q2 2024 was Jane Street, an estimated $9.28M added.
  • The largest ImmunityBio seller in Q2 2024 was State Street, an estimated $41.7M sold.

Based on aggregated 13F filings for Q2 2024.